Olmesartan is a commonly prescribed hypertension/high blood pressure medication. The researchers linked its use to GI issues including nausea, vomiting, diarrhea, weight loss and electrolyte abnormalities, which are common symptoms in patients with celiac disease.
“It’s really an awareness issue,” said Mayo Clinic gastroenterologist Joseph Murray, MD, in the release. “We want doctors to be aware of this issue, so if they see a patient who is having this type of syndrome — they think about medications as a possible association. We’ve reported an association. What needs to be known next is the science to understand why there is such an association.”
The research is published in the medical journal Mayo Clinic Proceedings.
Related Articles on Gastroenterology:
Gastroenterologist Dr. David Pound Discusses Hep C, Risk for Baby Boomers
Study: Six-Food Elimination Diet Improves EoE Symptons
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
